Molecules 2012, 17(10), 11570-11584; doi:10.3390/molecules171011570

Article
An Expeditious Iodine-Catalyzed Synthesis of 3-Pyrrole-substituted 2-Azetidinones
Debasish Bandyopadhyay , Jessica Cruz , Ram N. Yadav and Bimal K. Banik *
Department of Chemistry, The University of Texas-Pan American, 1201 West University Drive, Edinburg, TX 78539, USA
Undergraduate research participant.
*
Author to whom correspondence should be addressed; Email: banik@utpa.edu; Tel.: +1-956-665-8741; Fax: +1-956-384-5006.
Received: 10 September 2012; in revised form: 25 September 2012 / Accepted: 26 September 2012 /
Published: 28 September 2012

Abstract

: 2-Azetidinones and pyrroles are two highly important classes of molecules in organic and medicinal chemistry. A green and practical method for the synthesis of 3-pyrrole-substituted 2-azetidinones using catalytic amounts of molecular iodine under microwave irradiation has been developed. Following this method, a series of 3-pyrrole- substituted 2-azetidinones have been synthesized with a variety of substituents at N-1 and at C-4. The procedure is equally effective for mono- as well as polyaromatic groups at the N-1 position of the 2-azetidinone ring. The C-4 substituent has no influence either on the yield or the rate of the reaction. Optically pure 3-pyrrole-substituted 2-azetidinones have also been synthesized following this methodology. No deprotection/rearrangement has been identified in this process, even with highly acid sensitive group-containing substrates. A plausible mechanistic pathway has also been suggested based on the evidence obtained from 1H-NMR spectroscopy. The extreme rapidity with excellent reaction yields is believed to be the result of a synergistic effect of the Lewis acid catalyst (molecular iodine) and microwave irradiation.
Keywords:
iodine; microwave; 2-azetidinone; pyrrole; catalysis; green synthesis

1. Introduction

Since Fleming’s discovery of penicillin from the mould Penicillium notatum in 1928, β-lactam antibiotics remain as one of the most important contributions of science to mankind. The 2-azetidinone (commonly known as β-lactam) ring system is the basic structural feature of a number of broad spectrum β-lactam antibiotics, including penicillins, cephalosporins, carbapenems, nocardicins, monobactams, clavulanic acid, sulbactams and tazobactams, which have been widely used as therapeutic agents to treat bacterial infections and several other diseases [1,2,3,4,5,6,7,8,9,10,11,12,13,14]. The discovery of the nocardicins and monobactams has demonstrated for the first time that β-lactams do not require a conformationally constrained bicyclic structure to possess pharmacological activities, suggesting that the medicinal activity is strictly correlated to the presence of a suitably functionalized 2-azetidinone ring. The biological activity of the β-lactams is generally believed to be associated with the chemical reactivity of the four-membered ring and on the substituents especially at nitrogen of the 2-azetidinone ring [15]. Staudinger’s ketene-imine [2+2] cycloaddition reaction [16] is the most common method for the synthesis of β-lactams.

Like 2-azetidinones, pyrroles have occupied a central position in drug discovery since its inception (1884) over one hundred years ago, initially by reason of their occurrence in the key molecules of life, such as haemoglobin, chlorophyll, vitamin B12, porphyrins, bile pigments, coenzymes and more recently, because of their role as components of pharmaceuticals [currently, one of the best selling drugs, Lipitor (atorvastatin), has a pyrrole in its core] [17]. Pyrrole derivatives have also been reported as antimicrobial and antioxidant [18,19], anti-HIV [20], anticancer [21,22], antagonists of 5-HT7 receptor [23], antihepatitis [24] and antifungal agents [25] as well as cognition enhancers [26]. Besides these, this moiety is also present in several synthetic pharmaceuticals as well as electrically conducting polymers [27,28,29]. This general importance of pyrroles has prompted chemists to find new ways to synthesize pyrrole and its derivatives.

In recent years, renewed interest has been focused on the synthesis and modification of β-lactam ring to obtain compounds with diverse pharmacological activities. As a part of our ongoing research on synthesis of anticancer agents [30,31,32,33], some of our [34,35,36] trans-acetoxy β-lactams have demonstrated selective anticancer activity against a number of human cancer cell lines in vitro and in vivo. This finding has provided justification to develop an efficient synthesis of pyrrole-substituted β-lactams, based on the chemistry shown in Scheme 1.

Molecules 17 11570 g001
Scheme 1. Molecular iodine-catalyzed synthesis of 3-pyrrole substituted 2-azetidinones under solventless condition.

Click here to enlarge figure

Scheme 1. Molecular iodine-catalyzed synthesis of 3-pyrrole substituted 2-azetidinones under solventless condition.
Molecules 17 11570 g001

2. Results and Discussion

2.1. Results

Molecular iodine has acquired an important role in organic synthesis due to its unique and powerful features [37,38,39,40,41,42,43,44,45] as a Lewis acid. In recent years, the use of molecular iodine in organic chemistry has received considerable attention mainly because molecular iodine is moisture-stable, less toxic than alternative acidic catalysts, inexpensive and readily available. We have demonstrated the catalytic activity of molecular iodine in several of our earlier studies which include glycosylation [46,47], Michael reaction [48], deprotection of acetals and ketals [49], synthesis of pyrroles [50] and synthesis of quinoxalines [51]. On the other hand, we have been engaged in the study of microwave-induced reactions for many years. Using microwave irradiation technique we have successfully developed several new methodologies which include stereoselective synthesis of β-lactams [52,53,54], synthesis of pyrroles [55,56,57,58], aza-Michael addition [59], hydrolysis of amides [60], and electrophilic substitution of indoles [61,62]. During the course of present study, it has been conceived that 3-pyrrole-substituted 2-azetidinones could easily be prepared from the corresponding primary amine using molecular iodine as the catalyst under microwave irradiation. This idea has been extended in this paper through the reaction between 3-amino-2-azetidinones with 2,5-dimethoxytetrahydrofuran in the presence of catalytic amount of molecular iodine under solvent-free condition.

Our initial work started with screening of catalyst loading and solvent so as to identify optimal reaction conditions for the synthesis of 3-pyrrole-substituted 2-azetidinones. First of all, a number of solvents with different polarity have been screened using 1 mmol of (±)-trans 3-amino-1-(chrysen-6-yl)-4-phenylazetidin-2-one with 1.2 mmol of 2,5-dimethoxytetrahydrofuran using molecular iodine as catalyst (20 mol%) as a model reaction under automated CEM microwave irradiation conditions (300 Watts, 90 °C, 3 min). The results are summarized in Table 1.

Table Table 1. Microwave-assisted (300 Watts, 90 °C, 24–50 psi) synthesis of 3-pyrrole substituted 2-azetidinones from 1 mmol of (±)-trans 3-amino-1-(chrysen-6-yl)-4-phenylazetidin-2-one with 1.2 mmol of 2,5-dimethoxytetrahydrofuran using molecular iodine as catalyst (20 mol%) for 3 min: solvent optimization.

Click here to display table

Table 1. Microwave-assisted (300 Watts, 90 °C, 24–50 psi) synthesis of 3-pyrrole substituted 2-azetidinones from 1 mmol of (±)-trans 3-amino-1-(chrysen-6-yl)-4-phenylazetidin-2-one with 1.2 mmol of 2,5-dimethoxytetrahydrofuran using molecular iodine as catalyst (20 mol%) for 3 min: solvent optimization.
EntrySolvent (1 mL)Yield (%) a
1Water83
2THF77
3Ethanol70
4Toluene51
5Methanol69
6Dichloromethane48
7DMSO66
8Neat91

a isolated yield.

The results suggest that the absence of solvent is convenient for this reaction (Entry 8, Table 1). In the absence of any catalyst (only microwave irradiation under solventless condition) the same reaction has produced 21% yield in three minutes. The yield of the desired 2-azetidinone could be increased to 32% if the reaction is conducted for 30 minutes. The same reaction is used to optimize the amount of the catalyst to identify the best conditions (Table 2). The results show that 10 mol% molecular iodine is required to complete the reaction within three minutes (Entry 5, Table 2).

Table Table 2. Microwave-assisted (300 Watts, 90 °C, 24–50 psi) synthesis of 3-pyrrole substituted 2-azetidinones from 1 mmol of (±)-trans 3-amino-1-(chrysen-6-yl)-4-phenylazetidin-2-one with 1.2 mmol of 2,5-dimethoxytetrahydrofuran using molecular iodine as catalyst under neat condition for 3 min: optimization of the amount of the catalyst.

Click here to display table

Table 2. Microwave-assisted (300 Watts, 90 °C, 24–50 psi) synthesis of 3-pyrrole substituted 2-azetidinones from 1 mmol of (±)-trans 3-amino-1-(chrysen-6-yl)-4-phenylazetidin-2-one with 1.2 mmol of 2,5-dimethoxytetrahydrofuran using molecular iodine as catalyst under neat condition for 3 min: optimization of the amount of the catalyst.
EntryMolecular I2 (mol%)Yield (%) a
13078
22582
32091
41592
51098
6569
7254
8147

a isolated yield.

Considering these observations, next we have carried out a series of reactions using various 3-amino- substituted 2-azetidinones (1 mmol), 2,5-dimethoxytetrhydrofuran (1.2 mmol) under solventless conditions under the catalytic influence of molecular iodine (10 mol%) following an automated microwave-assisted procedure (300 Watts, 90 °C, 24–50 psi; Condition A) as well as stirring the reaction mixture at room temperature (Condition B). To verify the efficacy of the newly developed method, optically pure 3-amino-2-azetidinones were subjected to the reaction conditions and the corresponding pyrrole derivatives are isolated in good to excellent yields (Entries 10, 11, Table 3), both at room temperature, as well as in the microwave-induced procedure (Scheme 2).

Molecules 17 11570 g002
Scheme 2. Synthesis of 3-pyrrole substituted optically pure 2-azetidinones.

Click here to enlarge figure

Scheme 2. Synthesis of 3-pyrrole substituted optically pure 2-azetidinones.
Molecules 17 11570 g002

It is important to note that no deprotection/rearrangement is observed in the synthesis of pyrroles. The whole series of reactions was repeated at room temperature (stirring) under solventless conditions but the reactions have produced lower yields after much longer times (Table 3). The reaction has proceeded equally well irrespective of the nature of the substituents at C–4 (aryl, heteroaryl, ferrocenyl or 2,2-dimethyl-1,3-dioxolanyl). No stereochemical change has been noticed in any examples. The results obtained from both the methods (Condition A and Condition B) are summarized in Table 3.

Table Table 3. Molecular iodine-catalyzed microwave-assisted synthesis of 3-pyrrole substituted 2-azetidinones following Scheme 1 and Scheme 2.

Click here to display table

Table 3. Molecular iodine-catalyzed microwave-assisted synthesis of 3-pyrrole substituted 2-azetidinones following Scheme 1 and Scheme 2.
EntrySubstrateProductCondition A (MWI)Condition B
300 Watts/90 °C/24–50 psiStirring at room
temperature
Time (min)Yield (%) aTime (h)Yield (%) a
1 Molecules 17 11570 i001 Molecules 17 11570 i0021961272
2 Molecules 17 11570 i003 Molecules 17 11570 i0041931274
3 Molecules 17 11570 i005 Molecules 17 11570 i0061991275
4 Molecules 17 11570 i007 Molecules 17 11570 i0081941273
5 Molecules 17 11570 i009 Molecules 17 11570 i0103872463
6 Molecules 17 11570 i011 Molecules 17 11570 i0123902459
7 Molecules 17 11570 i013 Molecules 17 11570 i0143922461
8 Molecules 17 11570 i015 Molecules 17 11570 i0163982471
9 Molecules 17 11570 i017 Molecules 17 11570 i0183952467
10 Molecules 17 11570 i019 Molecules 17 11570 i0201931270
11 Molecules 17 11570 i021 Molecules 17 11570 i0221971273

a isolated yield.

It is very convenient to conduct reactions with molecular iodine because of its stability in the presence of moisture and oxygen. In all the cases, the reactions are completed within 1–3 min and the products are obtained in excellent yield (Table 3). The 3-amino-2-azetidinones were synthesized following the procedure published from our laboratory [63,64].

2.2. Discussion

Reaction of N-aryl imines with N-phthaloylglycine in the presence of triethylamine and 2-chloro-N-methylpyridinium iodide was performed at 0 °C–room temperature. This reaction produced a mixture of (±)-cis and (±)-trans 2-azetidinones. However, polyaromatic imine derived from 6-chrysenyl amine produced exclusively (±)-trans 2-azetidinones. The formation of a diastereoisomeric mixture in the case of N-monoaromatic imines had cast doubt about the analysis of the product distributions of earlier studies [54,65,66,67], where the formation of trans isomer was reported. It appears that the electron- withdrawing aromatic groups at the C- and N-terminus of the imine are responsible for the formation of the trans isomer, whose formation was rationalized through an isomerization of the enolate as described [30,31,32,52] earlier. Polyaromatic groups (in this example, 6-chrysenyl) at the nitrogen stabilize the iminium ion greatly. The electron-withdrawing properties of monocyclic aromatic groups at the N-site of the imine were not sufficient to have a complete isomerization of the enolate and therefore, a mixture of cis- and trans-isomer was formed. A series of 3-pyrrole-substituted 2-azetidinones were synthesized from 3-amino-2-azetidinones in the presence of molecular iodine (10 mol%) as catalyst under microwave irradiation under solventless conditions. Although the mechanism of the reaction was not studied in detail, based on 1H-NMR data, a plausible mechanistic pathway may be suggested (Scheme 3).

Molecules 17 11570 g003
Scheme 3. Plausible mechanistic pathway for the synthesis of 3-amino-2-azetidinones.

Click here to enlarge figure

Scheme 3. Plausible mechanistic pathway for the synthesis of 3-amino-2-azetidinones.
Molecules 17 11570 g003

A deprotection reaction of the methoxy groups in 2,5-dimethoxytetrahydrofuran takes place under mild acidic conditions and this process can be extremely accelerated by microwave irradiation. The intermediate dialdehyde (Scheme 3) reacts with 3-amino-β-lactams to produce the corresponding 3-pyrrole-substituted β-lactams following a nucleophilic addition and subsequent dehydration-aromatization route. This reaction suggests the competence of molecular iodine to serve as a Lewis activator. 1H-NMR spectroscopy has been used to provide additional support for the proposed mechanism. Upon irradiating a CDCl3 solution of 2,5-dimethoxytetrahydrofuran for 3 min in the presence of a catalytic amount of iodine, a 1H-NMR was taken. A highly intense downfield signal due to the –CHO group is observed. This clearly suggests the formation of the reactive dialdehyde in the reaction media. Under the influence of the electrophilic reagent, molecular iodine, demethylation of the methoxy groups in 2,5-dimethoxytetrahydrofuran takes place.

Application of microwave technology to the rapid synthesis of biologically significant heterocyclic molecules under solvent-free condition is very promising and challenging. The ultimate aim, of course is to conduct the reactions under solvent-free condition [68]. Development of cleaner technologies is a major emphasis in green chemistry. The combination of solvent-free reaction condition and microwave-irradiation is used as an eco-friendly approach for the synthesis of a variety of products and this generally leads to reduction in reaction times, enhances conversions, and changes of stereoselectivity of the product. Microwaves, as a part of the electromagnetic spectrum, are composed of two field components: electric and the magnetic. For the purpose of heating, the electric component is important as it results in a force being applied to all the polar or charged species. Such species, in response to the electric field, start to move or rotate and this causes additional polarization of the polar species in the vicinity. When dipolar species are subjected to the electric component of microwave fields they start to oscillate, following the oscillation of the electric field. During such oscillation, the polar or charged species collide with neighboring particles (charged or neutral). This rapid motion and resulting intermolecular friction cause an intense internal heat that can increase the rate of reaction [69,70]. It is obvious that the dielectric properties of the material under consideration are of paramount importance. In presence of microwaves, molecular iodine increases the “anionic activation” [71] because of its Lewis acidic character. Due to this reason the relative permittivity (ability of a molecule to be polarized by the application of an electric field) of the carbonyl groups, of the intermediate dialdehyde increases (Scheme 3), which facilitates microwave heating extensively. The larger the relative permittivity of a substance, the greater will be the coupling with microwaves [72]. When the reagents are subjected to microwave irradiation, microwaves pass through the (glass) walls of the reaction vessel and only heat the reactants, avoiding local overheating at the reaction walls. This can eliminate formation of side products and helps to explain the higher yields and purities typically observed. The extreme rapidity with excellent yield of the reaction can be rationalized as a synergistic effect of the Lewis acid catalyst (molecular iodine) and microwave irradiation.

3. Experimental

3.1. General

Melting points were determined in a Fisher Scientific electrochemical Mel-Temp* manual melting point apparatus (Model 1001) equipped with a 300 °C thermometer. FT-IR spectra were registered on a Bruker IFS 55 Equinox FTIR spectrophotometer as KBr discs. 1H-NMR (600 MHz) and 13C-NMR (150 MHz) spectra were obtained at room temperature with Bruker superconducting UltrashieldTM Plus 600 MHz NMR spectrometer with central field 14.09 Tesla, coil inductance 89.1 Henry and magnetic energy 1127.2 kJ using CDCl3 as solvent. Elemental analyses (C, H, N) were conducted using the Perkin-Elmer 2400 series II elemental analyzer, their results were found to be in good agreement (±0.2%) with the calculated values for C, H, N. All the reagents (analytical grade) were purchased from Sigma-Aldrich Corporation (St. Louis, MO, USA). Throughout the project solvents were purchased from Fisher-Scientific (Pittsburgh, PA, USA). Deionized water was used for the preparation of all aqueous solutions.

3.2. General Procedure for the Synthesis of 3-Pyrrole Substituted 2-Azetidinones from 3-Amino-2-azetidinones under Microwave Irradiation

The substrate (3-amino-2-azetidinones, 1.0 mmol), 2,5-dimethoxytetrahydrofuran (1.2 mmol) and iodine (10 mol%) were mixed together in a microwave vial. A small magnetic stir bar was placed in the reaction mixture. The mixture was irradiated in an automated microwave (CEM Corporation, Matthews, NC, USA) and the progress of the reaction was monitored by TLC. After completion of the reaction (Table 3), diethyl ether (10 mL) was added to the reaction mixture and the organic layer was washed with saturated sodium bicarbonate solution, brine and water successively. It was dried over anhydrous sodium sulfate and the solvent was removed under reduced pressure. The crude mass was purified through a small silica gel column using ethyl acetate/hexanes as eluent. The physical and spectral data [73] of the 3-pyrrole substituted 2-azetidinones are as follows:

(±)-cis-1,4-Diphenyl-3-(1H-pyrrol-1-yl)azetidin-2-one (Entry 1, Table 3). White solid (96%); mp 158 °C; IR: 3247, 2913, 1759, 1516, 1450, 1291, 1115, 712 cm−1; 1H-NMR: δ 5.43 (d, J = 5.41 Hz, 1H), 5.74 (d, J = 5.40 Hz, 1H), 5.87 (t, J = 2.04 Hz, 2H), 6.47 (t, J = 2.04, 2H), 7.14–7.42 (m, 10H); 13C-NMR: δ 62.12, 68.43, 109.08, 117.90, 120.44, 125.05, 126.77, 128.60, 129.59, 132.67, 137.84, 162.03. Anal. Calcd for C19H17N2O: C, 79.14; H, 5.59; N, 9.72. Found: C, 79.01; H, 5.52; N, 9.63.

(±)-trans-1,4-Diphenyl-3-(1H-pyrrol-1-yl)azetidin-2-one (Entry 2, Table 3). White solid (93%); mp 155 °C; IR: 3128, 2945, 2914, 1750, 1593, 1493, 1447, 1375, 1317, 1222, 1133, 1084, 961, 896, 728, 705 cm−1; 1H-NMR: δ 4.97 (d, J = 1.92 Hz, 1H), 5.12 (d, J = 2.04 Hz, 1H), 6.26 (t, J = 1.98 Hz, 2H), 6.77 (t, J = 1.92 Hz, 2H), 7.09–7.42 (m, 10H); 13C-NMR: δ 65.36, 73.25, 110.08, 117.68, 119.58, 124.78, 125.89, 126.01, 129.14, 129.48, 135.68, 136.78, 161.93. Anal. Calcd for C19H17N2O: C, 79.14; H, 5.59; N, 9.72. Found: C, 79.08; H, 5.56; N, 9.65.

(±)-cis-1-(4-Methoxyphenyl)-4-phenyl-3-(1H-pyrrol-1-yl)azetidin-2-one (Entry 3, Table 3). White crystalline solid (99%); mp 162 °C; IR: 3060, 2966, 1742, 1510, 1488, 1388, 1297, 1242, 1172, 1092, 808, 725, 692 cm−1; 1H-NMR: δ 3.77 (s, 3H), 5.39 (d, J = 5.28 Hz, 1H), 5.76 (d, J = 5.34 Hz, 1H), 5.88 (t, J = 2.04 Hz, 2H), 6.47 (t, J = 1.98 Hz, 2H), 6.83 (d, J = 9.0 Hz, 2H), 7.11–7.27 (m, 5H), 7.36 (d, J = 9.0 Hz, 2H); 13C-NMR: δ 55.48, 62.02, 68.23, 109.04, 114.48, 118.79, 120.17, 126.65, 128.31, 128.53, 130.69, 132.55, 156.66, 161.07. Anal. Calcd for C20H18N2O2: C, 75.45; H, 5.70; N, 8.80. Found: C, 75.31; H, 5.63; N, 8.72.

(±)-trans-1-(4-Methoxyphenyl)-4-phenyl-3-(1H-pyrrol-1-yl)azetidin-2-one (Entry 4, Table 3). White crystalline solid (94%); mp 145 °C; IR: 3126, 2958, 2931, 1757, 1728, 1514, 1463, 1450, 1382, 1321, 1288, 1258, 1135, 1091, 1069, 1036, 827, 740, 727 cm−1; 1H-NMR: δ 3.74 (s, 3H), 4.93 (d, J = 2.04 Hz, 1H), 5.10 (d, J = 2.04 Hz, 1H), 6.25 (t, J = 2.16 Hz, 2H), 6.76 (t, J = 2.10 Hz, 2H), 6.80 (d, J = 2.16 Hz, 1H), 6.81 (d, J = 2.22 Hz, 1H), 7.28–7.40 (m, 7H); 13C-NMR: δ 55.45, 65.44, 73.24, 110.00, 114.47, 119.02, 119.56, 125.95, 129.10, 129.44, 130.87, 135.74, 156.65, 161.29. Anal. Calcd for C20H18N2O2: C, 75.45; H, 5.70; N, 8.80. Found: C, 75.36; H, 5.59; N, 8.74.

(±)-trans-1-(Chrysen-6-yl)-4-(ferrocenyl)-3-(1H-pyrrol-1-yl)azetidin-2-one (Entry 5, Table 3). Orange crystalline solid (87%); mp 208 °C; IR: 2360, 1754, 1593, 1490, 1439, 1381, 1314, 1105, 819, 756, 727 cm−1; 1H-NMR: δ 3.82 (s, 5H), 4.02 (m, 1H), 4.07 (m, 1H), 4.16 (m, 1H), 4.24 (m, 1H), 5.29 (d, J = 2.28 Hz, 1H), 5.43 (d, J = 2.28 Hz, 1H), 6.32 (t, J = 2.10 Hz, 2H), 6.98 (d, J = 2.28 Hz, 2H), 7.48–8.76 (m, 11H); 13C-NMR: δ 65.72, 68.58, 68.68, 69.03, 69.43, 70.84, 82.63, 110.28, 117.96, 119.83, 120.92, 123.00, 123.81, 123.93, 126.82, 127.01, 127.10, 127.47, 127.82, 127.99, 128.13, 128.69, 130.15, 130.64, 131.54, 132.28, 164.27. Anal. Calcd for C35H26FeN2O: C, 76.93; H, 4.80; N, 5.13. Found: C, 76.81; H, 4.69; N, 5.06.

trans-1-(Chrysen-6-yl)-4-(pyridin-2-yl)-3-(1H-pyrrol-1-yl)azetidin-2-one (Entry 6, Table 3). White solid (90%); mp 224 °C; IR: 3057, 1756, 1591, 1488, 1471, 1437, 1393, 1318, 1141, 1095, 1070, 816, 761 cm−1; 1H-NMR: δ 5.56 (d, J = 1.68 Hz, 1H), 5.88 (d, J = 1.68 Hz, 1H), 6.35 (t, J = 1.92 Hz, 2H), 7.02 (t, J = 1.95 Hz, 2H), 7.16–8.78 (m, 15H); 13C-NMR: δ 68.18, 70.19, 110.10, 117.45, 119.98, 120.82, 122.63, 123.91, 124.10, 126.96, 127.03, 127.45, 127.51, 127.88, 128.02, 128.62, 130.10, 130.76, 131.49, 132.18, 136. 94, 150.54, 154.62, 163.99. Anal. Calcd for C30H21N3O: C, 81.98; H, 4.82; N, 9.56. Found: C, 81.89; H, 4.76; N, 9.49.

(±)-trans-1-(Chrysen-6-yl)-3-(1H-pyrrol-1-yl)-4-(thiophen-2-yl)azetidin-2-one (Entry 7, Table 3). Yellow solid (92%); mp 150 °C; IR: 1762, 1593, 1487, 1438, 1389, 1371, 816 cm−1; 1H-NMR: δ 5.58 (d, J = 2.04 Hz, 1H), 5.76 (d, J = 1.98 Hz, 1H), 6.36 (t, J = 1.92 Hz, 2H), 6.88 (dd, J = 3.78 Hz, 1.08 Hz, 1H), 6.98 (t, J = 2.04 Hz, 2H), 7.11 (d, J = 3.36 Hz, 1H), 7.23 (d, J = 4.98 Hz, 1H), 7.61–8.79 (m, 11H); 13C-NMR: δ 63.87, 72.90, 110.28, 110.36, 116.99, 119.74, 119.83, 120.85, 122.91, 123.73, 124.02, 126.56, 126.81, 126.99, 127.08, 127.29, 127.32, 127.42, 127.50, 128.01, 128.12, 128.66, 130.08, 130.19, 131.56, 132.22, 138.95, 163.22. Anal. Calcd for C29H20N2OS: C, 78.35; H, 4.53; N, 6.30. Found: C, 78.21; H, 4.45; N, 6.24.

(±)-trans-1-(Chrysen-6-yl)-4-phenyl-3-(1H-pyrrol-1-yl)azetidin-2-one (Entry 8, Table 3). White solid (98%); mp 124 °C; IR: 2919, 2353, 2323, 1762, 1707, 1593, 1488, 1455, 1438, 1387, 1346, 1314, 1092, 1070, 817 cm−1; 1H-NMR: δ 5.44 (d, J = 2.02 Hz, 1H), 5.54 (d, J = 2.02 Hz, 1H), 6.35 (t, J = 2.08 Hz, 2H), 6.96 (t, J = 2.12 Hz, 2H), 7.27–7.98 (m, 11H), 8.41–8.81 (m, 11H); 13C-NMR: δ 67.51, 7191, 110.25, 115.53, 119.74, 120.87, 122.85, 123.72, 124.30, 126.33, 126.79, 126.92, 127.03, 127.46, 127.50, 127.72, 127.92, 128.67, 129.21, 129.35, 130.01, 130.89, 131.61, 132.24, 135.71, 163.46. Anal. Calcd for C31H22N2O: C, 84.91; H, 5.06; N, 6.39. Found: C, 84.77; H, 4.97; N, 6.31.

(±)-trans-1-(Chrysen-6-yl)-4-(4-methoxyphenyl)-3-(1H-pyrrol-1-yl)azetidin-2-one (Entry 9, Table 3). Light yellow solid (95%); mp 160 °C; IR: 3099, 2990, 2357, 1755, 1603, 1509, 1478, 1439, 1232, 1173, 1142, 1095, 1017, 958, 821, 743 cm−1; 1H-NMR: δ 3.71 (s, 3H), 5.35 (d, J = 2.22 Hz, 1H), 5.41 (d, J = 2.16 Hz, 1H), 6.27 (t, J = 2.10 Hz, 2H), 6.74 (d, J = 8.64 Hz, 2H), 6.88 (t, J = 2.10 Hz, 2H), 7.31 (d, J = 8.58 Hz, 2H), 7.63–8.82 (m, 11H); 13C-NMR: δ 55.27, 67.35, 71.99, 110.17, 114.75, 115.77, 119.74, 120.87, 122.88, 123.71, 124.27, 126.77, 126.91, 127.00, 127.01, 127.45, 127.48, 127.69, 127.77, 127.88, 128.66, 130.03, 130.81, 131.59, 132.24, 160.28, 163.63. Anal. Calcd for C32H24N2O2: C, 82.03; H, 5.16; N, 5.98. Found: C, 81.96; H, 5.11; N, 5.90.

(3R,4R)-4-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-1-phenyl-3-(1H-pyrrol-1-yl)azetidin-2-one (Entry 10, Table 3). Pale yellow crystalline solid (93%); mp 131 °C; IR: 2918, 1766, 1593, 1570, 1370, 1204, 1095, 822, 730, 691 cm−1; 1H-NMR: δ 1.17 (s, 3H), 1.40 (s, 3H), 2.88 (t, J = 7.02 Hz, 1H), 3.26 (m, 1H), 4.05 (dd, J = 11.01, 8.16 Hz, 1H), 4.29 (m, 1H), 5.44 (d, J = 5.58 Hz, 1H), 6.16 (s, 2H), 6.62 (s, 2H), 7.09 (t, J = 7.38 Hz, 1H), 7.29 (t, J = 7.80 Hz, 2H), 7.73 (d, J = 8.22 Hz, 2H); 13C-NMR: δ 25.12, 26.52, 62.91, 64.82, 65.76, 77.21, 109.81, 110.55, 118.78, 120.69, 124.99, 128.98, 137.55, 162.19. Anal. Calcd for C18H20N2O3: C, 69.21; H, 6.45; N, 8.97. Found: C, 69.11; H, 6.40; N, 8.90.

(3R,4R)-4-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-1-(4-methoxyphenyl)-3-(1H-pyrrol-1-yl)azetidin-2-one (Entry 11, Table 3). White crystalline solid (97%); mp 142 °C; IR: 3122, 2986, 1738, 1514, 1385, 1237, 832, 736 cm−1; 1H-NMR: δ 1.18 (s, 3H), 1.39 (s, 3H), 2.87 (dd, J = 7.74, 3.24 Hz, 1H), 3.26 (t, J = 8.22 Hz, 1H), 3.74 (s, 3H), 4.03 (dd, J = 11.37, 7.32 Hz, 1H), 4.23 (dd, J = 7.08, 3.12 Hz, 1H), 5.41 (d, J = 5.52 Hz, 1H), 6.16 (s, 2H), 6.61 (s, 2H), 6.82 (d, J = 8.88 Hz, 2H), 7.67 (d, J = 8.88 Hz, 2H); 13C-NMR: δ 25.15, 26.54, 55.50, 63.04, 64.85, 65.78, 77.20, 109.78, 110.49, 114.09, 119.81, 120.68, 131.02, 156.84, 161.61. Anal. Calcd for C19H22N2O4: C, 66.65; H, 6.48; N, 8.18. Found: C, 66.49; H, 6.36; N, 8.04.

4. Conclusions

In summary, an extremely rapid, convenient and environmentally benign route for the one-step synthesis of 3-pyrrole-substituted 2-azetidinones was developed. The present simple methodology offers attractive features such as short reaction times and milder conditions, and produces the products in excellent yields. The procedure is equally effective with mono- and polyaromatic 2-azetidinones. This strategy should find application in the synthesis of various organic compounds of medicinal interest.

Acknowledgments

We gratefully acknowledge the funding support from Kleberg Foundation of Texas.

References

  1. Banik, B.K.; Banik, I.; Becker, F.F. Novel anticancer β-lactams. Top. Heterocycl. Chem. 2010, 22, 349–373, doi:10.1007/7081_2010_28.
  2. Banik, B.K.; Becker, F.F. Synthesis, electrophilic substitution and structure-activity relationship studies of polycyclic aromatic compounds towards the development of anticancer agents. Curr. Med. Chem. 2001, 8, 1513–1533.
  3. Bose, A.K.; Manhas, M.S.; Banik, B.K.; Srirajan, V. β-Lactams: Cyclic Amides of Distinction In The Amide Linkage: Selected Structural Aspects in Chemistry, Biochemistry, and Material Science; Greenberg, A., Breneman, C.M., Liebman, J.F., Eds.; Wiley-Interscience: New York, NY, USA, 2000; pp. 157–214. Chapter 7.
  4. Georg, G.I.; Ravikumar, V.T. The Organic Chemistry of β-Lactams; Georg, G.I., Ed.; VCH: New York, NY, USA, 1992.
  5. Alcaide, B.; Almendros, P. Allenyl-β-Lactams. Versatile scaffolds for the synthesis of heterocycles. Chem. Rec. 2011, 11, 311–330, doi:10.1002/tcr.201100011.
  6. Alcaide, B.; Almendros, P.; Aragoncillo, C. β-Lactams: versatile building blocks for the stereoselective synthesis of non-β-lactam products. Chem. Rev. 2007, 107, 4437–4492, doi:10.1021/cr0307300.
  7. Alcaide, B.; Almendros, P. β-Lactams as versatile synthetic intermediates for the preparation of heterocycles of biological interest. Curr. Med. Chem. 2004, 11, 1921–1949.
  8. Deshmukh, A.R.A.S.; Bhawal, B.M.; Krishnaswamy, D.; Govande, V.V.; Shinkre, B.A.; Jayanthi, A. Azetidin-2-ones, synthon for biologically important compounds. Curr. Med. Chem. 2004, 11, 1889–1920.
  9. Alcaide, B.; Almendros, P. Selective bond cleavage of the β-lactam nucleus: Application in stereocontrolled synthesis. Synlett 2002, 3, 381–393, doi:10.1055/s-2002-20448.
  10. Palomo, C.; Aizpurua, J.M.; Ganboa, I.; Oiarbide, M. β-Lactams as versatile intermediates in α- and β-amino acid synthesis. Synlett 2001, 12, 1813–1826.
  11. Alcaide, B.; Almendros, P. 4-Oxoazetidine-2-carbaldehydes as useful building blocks in stereocontrolled synthesis. Chem. Soc. Rev. 2001, 30, 226–240.
  12. Alcaide, B.; Almendros, P.; Luna, A. The chemistry of 2-azetidinones (β-Lactams). In Modern Heterocyclic Chemistry; Alvarez-Builla, J., Vaquero, J.J., Barluenga, J., Eds.; WILEY-VCH: Weinheim, Germany, 2011; Volume 4, pp. 2117–2173. Chapter 24.
  13. Alcaide, B.; Almendros, P.; María, C.R. Domino metal-free allene-β-lactam-based access to functionalized pyrroles. Chem. Commun. 2006, 2616–2618.
  14. Alcaide, B.; Almendros, P.; Carrascosa, R.; Redondo, M.C. New regiocontrolled synthesis of functionalized pyrroles from 2-azetidinone-tethered allenols. Chem. Eur. J. 2008, 14, 637–643, doi:10.1002/chem.200700788.
  15. Mehta, P.D.; Sengar, N.P.S.; Pathak, A.K. 2-Azetidinone—A new profile of various pharmacological activities. Eur. J. Med. Chem. 2010, 45, 5541–5560, doi:10.1016/j.ejmech.2010.09.035.
  16. Staudinger, H. Ketenes. 1. Diphenylketene. Liebigs Ann. 1907, 356, 51–123, doi:10.1002/jlac.19073560106.
  17. Gupton, J.T. Pyrrole natural products with antitumor properties. Top. Heterocycl. Chem. 2006, 2, 53–92, doi:10.1007/7081_019.
  18. Arumugam, N.; Raghunathan, R.; Almansour, A.I.; Karama, U. An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents. Bioorg. Med. Chem. Lett. 2012, 22, 1375–1379, doi:10.1016/j.bmcl.2011.12.061.
  19. Manvar, A.; Bavishi, A.; Radadiya, A.; Patel, J.; Vora, V.; Dodia, N.; Rawal, K.; Shah, A. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains. Bioorg. Med. Chem. Lett. 2011, 21, 4728–4731.
  20. Jiang, S.; Tala, S.R.; Lu, H.; Zou, P.; Avan, I.; Ibrahim, T.S.; Abo-Dya, N.E.; Abdelmajeid, A.; Debnath, A.K.; Katritzky, A.R. Design, synthesis, and biological activity of a novel series of 2,5-disubstituted furans/pyrroles as HIV-1 fusion inhibitors targeting gp41. Bioorg. Med. Chem. Lett. 2011, 21, 6895–6898.
  21. Fang, Z.; Liao, P.-C.; Yang, Y.-L.; Yang, F.-L.; Chen, Y.-L.; Lam, Y.; Hua, K.-F.; Wu, S.-H. Synthesis and biological evaluation of polyenylpyrrole derivatives as anticancer agents acting through caspases-dependent apoptosis. J. Med. Chem. 2010, 53, 7967–7978, doi:10.1021/jm100619x.
  22. Bandyopadhyay, D.; Mukherjee, S.; Granados, J.C.; Short, J.D.; Banik, B.K. Ultrasound-assisted bismuth nitrate-induced green synthesis of novel pyrrole derivatives and their biological evaluation as anticancer agents. Eur. J. Med. Chem. 2012, 50, 209–215, doi:10.1016/j.ejmech.2012.01.055.
  23. Rudolph, D.A.; Dvorak, C.A.; Dvorak, L.; Nepomuceno, D.; Bonaventure, P.; Lovenberg, T.W.; Carruthers, N.I. Novel tetrahydropyrido[3,2-c]pyrroles as 5-HT7 antagonists. Bioorg. Med. Chem. Lett. 2011, 21, 42–44.
  24. Ontoria, J.M.; Martin, H.J.I.; Malancona, S.; Attenni, B.; Stansfield, I.; Conte, I.; Ercolani, C.; Habermann, J.; Ponzi, S.; Di Filippo, M.; et al. Identification of thieno[3,2-b]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase. Bioorg. Med. Chem. Lett. 2006, 16, 4026–4030.
  25. Di Santo, R.; Tafi, A.; Costi, R.; Botta, M.; Artico, M.; Corelli, F.; Forte, M.; Caporuscio, F.; Angiolella, L.; Palamara, A.T. Antifungal agents. 11. N-Substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: Synthesis, anti-Candida activity, and QSAR studies. J. Med. Chem. 2005, 48, 5140–5153.
  26. Geronikaki, A.A.; Dearden, J.C.; Filimonov, D.; Galaeva, I.; Garibova, T.L.; Gloriozova, T.; Krajneva, V.; Lagunin, A.; Macaev, F.Z.; Molodavkin, G.; et al. Design of new cognition enhancers: from computer prediction to synthesis and biological evaluation. J. Med. Chem. 2004, 47, 2870–2876, doi:10.1021/jm031086k.
  27. Fuerstner, A. Venturing into catalysis based natural product synthesis. Synlett 1999, 1523–1533, doi:10.1055/s-1999-2880.
  28. Higgins, S.J. Conjugated polymers incorporating pendent functional groups-synthesis and characterization. Chem. Soc. Rev. 1997, 26, 247–258.
  29. McCullough, R.D.; Ewbank, P.C. Handbook of Conducting Polymers, 2nd ed.; Skotheim, T.A., Elsenbaumer, R.L., Reynolds, J.R., Dekker, M., Eds.; CRC Press: New York, NY, USA, 1998. Chapter 9.
  30. Becker, F.F.; Banik, B.K. Polycyclic aromatic compounds as anticancer agents: Synthesis and biological evaluation of some chrysene derivatives. Bioorg. Med. Chem. Lett. 1998, 8, 2877–2880, doi:10.1016/S0960-894X(98)00520-4.
  31. Becker, F.F.; Mukhopadhyay, C.; Hackfeld, L.; Banik, I.; Banik, B.K. Polycyclic aromatic compounds as anticancer agents: Synthesis and biological evaluation of dibenzofluorene derivatives. Bioorg. Med. Chem. 2000, 8, 2693–2699, doi:10.1016/S0968-0896(00)00213-3.
  32. Banik, B.K.; Becker, F.F. Polycyclic aromatic compounds as anticancer agents. 4. Structure-activity relationships of chrysene and pyrene derivatives. Bioorg. Med. Chem. 2001, 9, 593–605.
  33. Bandyopadhyay, D.; Granados, J.C.; Short, J.D.; Banik, B.K. Polycyclic aromatic compounds as anticancer agents: Evaluation of synthesis and in vitro cytotoxicity. Oncol. Lett. 2012, 3, 45–49.
  34. Banik, B.K.; Becker, F.F.; Banik, I. Synthesis of anticancer β-lactams: Mechanism of action. Bioorg. Med. Chem. 2004, 12, 2523–2528, doi:10.1016/j.bmc.2004.03.033.
  35. Banik, I.; Becker, F.F.; Banik, B.K. Stereoselective synthesis of β-lactams with polyaromatic imines: Entry to new and novel anticancer agents. J. Med. Chem. 2003, 46, 12–15, doi:10.1021/jm0255825.
  36. Banik, B.K.; Banik, I.; Becker, F.F. Stereocontrolled synthesis of anticancer β-lactams via the Staudinger reaction. Bioorg. Med. Chem. 2005, 13, 3611–3622, doi:10.1016/j.bmc.2005.03.044.
  37. Tekale, S.U.; Kauthale, S.S.; Dake, S.A.; Sarda, S.R.; Pawar, R.P. Molecular iodine, an efficient and versatile reagent for organic synthesis. Curr. Org. Chem. 2012, 16, 1485–1501, doi:10.2174/138527212800672574.
  38. Parvatkar, P.T.; Parameswaran, P.S.; Tilve, S.G. Recent developments in the synthesis of five- and six-membered heterocycles using molecular iodine. Chem. Eur. J. 2012, 18, 5460–5489, doi:10.1002/chem.201100324.
  39. Veisi, H. Molecular iodine: Recent application in heterocyclic synthesis. Curr. Org. Chem. 2011, 15, 2438–2468, doi:10.2174/138527211796150570.
  40. Zhdankin, V.V. Organoiodine (V) reagents in organic synthesis. J. Org. Chem. 2011, 76, 1185–1197, doi:10.1021/jo1024738.
  41. Togo, H.; Iida, S. Synthetic use of molecular iodine for organic synthesis. Synlett 2006, 14, 2159–2175, doi:10.1055/s-2006-950405.
  42. Das, S.; Borah, R.; Devi, R.R.; Thakur, A.J. Molecular iodine in protection and deprotection chemistry. Synlett 2008, 18, 2741–2762.
  43. Alcaide, B.; Almendros, P.; Cabrero, G.; Callejo, R.; Ruiz, M.P.; Arno, M.; Domingo, L.R. Ring expansion versus cyclization in 4-oxoazetidine-2-carbaldehydes catalyzed by molecular iodine: experimental and theoretical study in concert. Adv. Synth. Catal. 2010, 352, 1688–1700, doi:10.1002/adsc.201000171.
  44. Chen, C.-C.; Yang, S.-C.; Wu, M.-J. Iodine-mediated cascade cyclization of enediynes to iodinated benzo[a]carbazoles. J. Org. Chem. 2011, 76, 10269–10274, doi:10.1021/jo201795t.
  45. Lee, W.-C.; Shen, H.-C.; Hu, W.-P.; Lo, W.-S.; Murali, C.; Vandavasi, J.K.; Wang, J.-J. Iodine-catalyzed, stereo- and regioselective synthesis of 4-arylidine-4H-benzo[d][1,3]oxazines and their applications for the synthesis of quinazoline 3-oxides. Adv. Synth. Catal. 2012, 354, 2218–2228, doi:10.1002/adsc.201200018.
  46. Banik, B.K.; Zegrocka, O.; Manhas, M.S.; Bose, A.K. Studies on lactams. 104. Enantiomerically pure β-lactams with the thienamycin side chain via glycosylation. Heterocycles 1997, 27, 173–176.
  47. Banik, B.K.; Manhas, M.S.; Bose, A.K. Studies on lactams. 103. Enantiopure α-hydroxy-β-lactams via stereoselective glycosylation. Tetrahedron Lett. 1997, 38, 5077–5080, doi:10.1016/S0040-4039(97)01130-1.
  48. Banik, B.K.; Fernandez, M.; Alvarez, C. Iodine-catalyzed highly efficient Michael reaction of indoles under solvent-free condition. Tetrahedron Lett. 2005, 46, 2479–2482, doi:10.1016/j.tetlet.2005.02.044.
  49. Banik, B.K.; Garza, R. Molecular iodine-catalyzed deprotection of acetals and ketals in acetone. Chem. Edu. 2007, 12, 75–76.
  50. Bandyopadhyay, D.; Mukherjee, S.; Banik, B.K. An expeditious synthesis of N-substituted pyrroles via microwave-induced iodine-catalyzed reaction under solventless conditions. Molecules 2010, 15, 2520–2525, doi:10.3390/molecules15042520.
  51. Bandyopadhyay, D.; Mukherjee, S.; Rodriguez, R.R.; Banik, B.K. An effective microwave-induced iodine-catalyzed method for the synthesis of quinoxalines via condensation of 1,2-dicarbonyl compounds. Molecules 2010, 15, 4207–4212, doi:10.3390/molecules15064207.
  52. Bandyopadhyay, D.; Banik, B.K. Microwave-induced stereoselectivity of β-lactam formation with dihydrophenanthrenyl imines via Staudinger cycloaddition. Helv. Chim. Acta 2010, 93, 298–301, doi:10.1002/hlca.200900212.
  53. Bandyopadhyay, D.; Yañez, M.; Banik, B.K. Microwave-induced stereoselectivity of β-lactam formation: effects of solvents. Heterocycl. Lett. 2011, 1, 65–67.
  54. Bandyopadhyay, D.; Rivera, G.; Salinas, I.; Aguilar, H.; Banik, B.K. Iodine-catalyzed remarkable synthesis of novel N-polyaromatic β-lactams bearing pyrroles. Molecules 2010, 15, 1082–1088, doi:10.3390/molecules15021082.
  55. Andoh-Baidoo, R.; Danso, R.; Mukherjee, S.; Bandyopadhyay, D.; Banik, B.K. Microwave-induced N-bromosuccinimide-mediated novel synthesis of pyrroles via Paal-Knorr reaction. Heterocycl. Lett. 2011, 1, 107–109.
  56. Bandyopadhyay, D.; Banik, A.; Bhatta, S.; Banik, B.K. Microwave-assisted ruthenium trichloride catalyzed synthesis of pyrroles fused with indole systems. Heterocycl. Commun. 2009, 15, 121–122.
  57. Abrego, D.; Bandyopadhyay, D.; Banik, B.K. Microwave-induced indium-catalyzed synthesis of pyrrole fused with indolinone in water. Heterocycl. Lett. 2011, 1, 94–95.
  58. Rivera, S.; Bandyopadhyay, D.; Banik, B.K. Facile synthesis of N-substituted pyrroles  via microwave-induced bismuth nitrate-catalyzed reaction under solventless conditions. Tetrahedron Lett. 2009, 50, 5445–5448, doi:10.1016/j.tetlet.2009.06.002.
  59. Kall, A.; Bandyopadhyay, D.; Banik, B.K. Microwave-induced aza-Michael reaction in water: A remarkable simple procedure. Synth. Commun. 2010, 42, 1730–1735.
  60. Bandyopadhyay, D.; Fonseca, R.S.; Banik, B.K. Microwave-induced bismuth nitrate-mediated selective hydrolysis of amide. Heterocycl. Lett. 2011, 1, 75–77.
  61. Iglesias, L.; Aguilar, C.; Bandyopadhyay, D.; Banik, B.K. A new bismuth nitrate-catalyzed electrophilic substitution of indoles with carbonyl compounds under solventless conditions. Synth. Commun. 2010, 40, 3678–3682, doi:10.1080/00397910903531631.
  62. Rivera, S.; Bandyopadhyay, D.; Banik, B.K. Microwave-induced bismuth nitrate-catalyzed electrophilic substitution of 7-aza indole with activated carbonyl compound under solvent-free conditions. Heterocycl. Lett. 2011, 1, 43–46.
  63. Rivera, G.; Bandyopadhyay, D.; Jaggi, S.; Gonzales, R.C.; Banik, B.K. An expeditious synthesis of 3-amino β-lactams derived from polyaromatic compounds. Heterocycl. Commun. 2009, 15, 323–325.
  64. Bandyopadhyay, D.; Xavier, M.; Banik, B.K. Highly stereoselective β-lactam synthesis via the Staudinger reaction using polyaromatic imines. Heterocycl. Commun. 2009, 15, 229–232.
  65. Manhas, M.S.; Amin, S.G.; Ram, B.; Bose, A.K. Studies on lactams. Part L. Annulation of imines to β-lactams at low temperatures. Synthesis 1976, 10, 689–690.
  66. Bose, A.K.; Chiang, Y.H.; Manhas, M.S. β-Lactams. XXI. Mechanism of β-lactam formation. Tetrahedron Lett. 1972, 40, 4091–4094.
  67. Miyake, M.; Kirisawa, M.; Tokutake, N. A convenient synthesis of β-lactams. Synthesis 1982, 12, 1053–1056.
  68. Martins, M.A.P.; Frizzo, C.P.; Moreira, D.N.; Buriol, L.; Machado, P. Solvent-free heterocyclic synthesis. Chem. Rev. 2009, 109, 4140–4182.
  69. Kidwai, M. Green chemistry trends toward sustainability. Pure Appl. Chem. 2006, 78, 1983–1992, doi:10.1351/pac200678111983.
  70. Bandyopadhyay, D.; Maldonado, S.; Banik, B.K. A microwave-assisted bismuth nitrate-catalyzed unique route toward 1,4-dihydropyridines. Molecules 2012, 17, 2643–2662, doi:10.3390/molecules17032643.
  71. Kranjc, K.; Kočevar, M. Microwave-assisted organic synthesis: General considerations and transformations of heterocyclic compounds. Curr. Org. Chem. 2010, 14, 1050–1074, doi:10.2174/138527210791130488.
  72. Blackwell, H.E. Out of the oil bath and into the oven—Microwave-assisted combinatorial chemistry heats up. Org. Biomol. Chem. 2003, 1, 1251–1255, doi:10.1039/b301432k.
  73. Bandyopadhyay, D.; Cruz, J.; Banik, B.K. Novel synthesis of 3-pyrrole substituted β-lactams via microwave-induced bismuth nitrate-catalyzed reaction. Tetrahedron 2012. Ahead of Print.
  • Sample Availability: Samples of the all compounds (mg quantity) are available from the authors.
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert